Clinical and laboratory characteristics of 144 patients with mediterranean spotted fever

Eur J Clin Microbiol Infect Dis. 2003 Feb;22(2):126-8. doi: 10.1007/s10096-002-0879-x. Epub 2003 Feb 18.

Authors

E Antón¹, B Font, T Muñoz, I Sanfeliu, F Segura

Affiliation

¹ Department of Internal Medicine, Corporació Parc Taulí, Parc Taulí s/n, 08208, Sabadell, Barcelona, Spain. eanton@cspt.es

PMID: 12627290
DOI: 10.1007/s10096-002-0879-x

No abstract available

MeSH terms

Adolescent
Adult
Age Distribution
Aged
Aged, 80 and over
Anti-Bacterial Agents / therapeutic use
Blood Chemical Analysis
Boutonneuse Fever / diagnosis*
Boutonneuse Fever / drug therapy
Boutonneuse Fever / epidemiology*
Child
Child, Preschool
Clinical Laboratory Techniques
Female
Follow-Up Studies
Humans
Incidence
Josamycin / therapeutic use
Male
Middle Aged
Prospective Studies
Registries
Rickettsia conorii / drug effects
Rickettsia conorii / isolation & purification*
Risk Factors
Serologic Tests / methods
Severity of Illness Index
Sex Distribution
Spain / epidemiology

Substances

Anti-Bacterial Agents
Josamycin